ANAVEX LIFE SCIENCES CORP. Information Technology and Data Processing
ANAVEX LIFE SCIENCES CORP. (AVXL) reported Information Technology and Data Processing of $12.46 thousand for the 3-month period ending 2013-12-31, per its 10-Q filed 2014-02-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:InformationTechnologyAndDataProcessing · last filed 2014-02-14
- ANAVEX LIFE SCIENCES CORP. information technology and data processing for the quarter ending 2013-12-31 was $12.46K, a 33.17% increase year-over-year.
- ANAVEX LIFE SCIENCES CORP. information technology and data processing for the quarter ending 2013-09-30 was $15.14K, a 150.80% increase year-over-year.
- ANAVEX LIFE SCIENCES CORP. information technology and data processing for the quarter ending 2013-06-30 was $3.38K, a 8.52% increase year-over-year.
- ANAVEX LIFE SCIENCES CORP. information technology and data processing for the quarter ending 2013-03-31 was $5.77K, a 37.54% decline year-over-year.
- ANAVEX LIFE SCIENCES CORP. information technology and data processing for fiscal 2013 was $33.63K, a 25.53% increase from fiscal 2012.
- ANAVEX LIFE SCIENCES CORP. information technology and data processing for fiscal 2012 was $26.79K, a 54.49% decline from fiscal 2011.
- ANAVEX LIFE SCIENCES CORP. information technology and data processing for fiscal 2011 was $58.88K, a 112.75% increase from fiscal 2010.
- ANAVEX LIFE SCIENCES CORP. information technology and data processing for fiscal 2010 was $27.68K.
| Period end | Information Technology and Data Processing 3 month | Information Technology and Data Processing 6 month | Information Technology and Data Processing 9 month | Information Technology and Data Processing 12 month | Information Technology and Data Processing 89 month | Information Technology and Data Processing 92 month | Information Technology and Data Processing 95 month | Information Technology and Data Processing 98 month | Information Technology and Data Processing 101 month | Information Technology and Data Processing 104 month | Information Technology and Data Processing 107 month | Information Technology and Data Processing 110 month | Information Technology and Data Processing 113 month | Information Technology and Data Processing 116 month | Information Technology and Data Processing 119 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2013-12-31 | $12.46K 10-Q · filed 2014-02-14 | $27.59K derived: sum of 2 quarters · filed 2014-02-14 | $30.97K derived: sum of 3 quarters · filed 2014-02-14 | $36.74K derived: sum of 4 quarters · filed 2014-02-14 | $200.49K 10-Q · filed 2014-02-14 | ||||||||||
| 2013-09-30 | $15.14K derived: 10-K 12 month − 10-Q 9 month · filed 2013-12-30 | $18.51K derived: sum of 2 quarters · filed 2013-12-30 | $24.28K derived: sum of 3 quarters · filed 2013-12-30 | $33.63K 10-K · filed 2013-12-30 | $188.03K 10-K · filed 2013-12-30 | ||||||||||
| 2013-06-30 | $3.38K 10-Q · filed 2013-08-14 | $9.14K derived: sum of 2 quarters · filed 2013-08-14 | $18.50K 10-Q · filed 2013-08-14 | $24.53K derived: sum of 4 quarters · filed 2014-02-14 | $172.90K 10-Q · filed 2013-08-14 | ||||||||||
| 2013-03-31 | $5.77K 10-Q · filed 2013-05-17 | $15.12K 10-Q · filed 2013-05-17 | $21.16K derived: sum of 3 quarters · filed 2014-02-14 | $24.27K derived: sum of 4 quarters · filed 2014-02-14 | $169.52K 10-Q · filed 2013-05-17 | ||||||||||
| 2012-12-31 | $9.35K 10-Q · filed 2014-02-14 | $15.39K derived: sum of 2 quarters · filed 2014-02-14 | $18.50K derived: sum of 3 quarters · filed 2014-02-14 | $27.74K derived: sum of 4 quarters · filed 2014-02-14 | $163.75K 10-Q · filed 2013-02-14 | ||||||||||
| 2012-09-30 | $6.04K derived: 10-K 12 month − 10-Q 9 month · filed 2013-12-30 | $9.14K derived: sum of 2 quarters · filed 2013-12-30 | $18.38K derived: sum of 3 quarters · filed 2013-12-30 | $26.79K 10-K · filed 2013-12-30 | $154.40K 10-K · filed 2012-12-31 | ||||||||||
| 2012-06-30 | $3.11K 10-Q · filed 2013-08-14 | $12.35K derived: sum of 2 quarters · filed 2013-08-14 | $20.76K 10-Q · filed 2013-08-14 | $24.83K derived: sum of 4 quarters · filed 2013-08-14 | $148.36K 10-Q · filed 2012-08-17 | ||||||||||
| 2012-03-31 | $9.24K 10-Q · filed 2013-05-17 | $17.65K 10-Q · filed 2013-05-17 | $21.72K derived: sum of 3 quarters · filed 2013-05-17 | $31.10K derived: sum of 4 quarters · filed 2013-05-17 | $145.25K 10-Q · filed 2012-05-15 | ||||||||||
| 2011-12-31 | $8.41K 10-Q · filed 2013-02-14 | $12.48K derived: sum of 2 quarters · filed 2013-02-14 | $21.86K derived: sum of 3 quarters · filed 2013-02-14 | $58.23K derived: sum of 4 quarters · filed 2013-02-14 | $136.02K 10-Q · filed 2012-02-14 | ||||||||||
| 2011-09-30 | $4.07K derived: 10-K 12 month − 10-Q 9 month · filed 2012-12-31 | $13.45K derived: sum of 2 quarters · filed 2012-12-31 | $49.82K derived: sum of 3 quarters · filed 2012-12-31 | $58.88K 10-K · filed 2012-12-31 | $127.60K 10-K · filed 2011-12-22 | ||||||||||
| 2011-06-30 | $9.38K 10-Q · filed 2012-08-17 | $45.74K derived: sum of 2 quarters · filed 2012-08-17 | $54.80K 10-Q · filed 2012-08-17 | $65.36K derived: sum of 4 quarters · filed 2012-08-17 | $123.53K 10-Q · filed 2011-08-12 | ||||||||||
| 2011-03-31 | $36.36K 10-Q · filed 2012-05-15 | $45.42K 10-Q · filed 2012-05-15 | $55.98K derived: sum of 3 quarters · filed 2012-05-15 | $63.65K derived: sum of 4 quarters · filed 2012-05-15 | |||||||||||
| 2010-12-31 | $9.06K 10-Q · filed 2012-02-14 | $19.62K derived: sum of 2 quarters · filed 2012-02-14 | $27.28K derived: sum of 3 quarters · filed 2012-02-14 | ||||||||||||
| 2010-09-30 | $10.55K derived: 10-K 12 month − 10-Q 9 month · filed 2011-12-22 | $18.22K derived: sum of 2 quarters · filed 2011-12-22 | $27.68K 10-K · filed 2011-12-22 | ||||||||||||
| 2010-06-30 | $7.67K 10-Q · filed 2011-08-12 | $17.12K 10-Q · filed 2011-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |